Xylem (XYL) Financials

$122.34 -1.91 (-1.54%)

Closing price 03:59 PM Eastern

Extended Trading

$122.30 -0.04 (-0.03%)

As of 06:19 PM Eastern

Annual Income Statements for Xylem

This table shows Xylem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	340	260	331	549	401	254	427	355	609	890
Consolidated Net Income / (Loss)	340	260	330	549	401	254	427	355	609	890
Net Income / (Loss) Continuing Operations	340	260	330	549	401	254	427	355	609	890
Total Pre-Tax Income	403	340	466	585	416	285	511	440	635	1,087
Total Operating Income	449	408	552	654	486	367	585	622	652	1,009
Total Gross Profit	1,404	1,462	1,847	2,026	2,046	1,830	1,975	2,084	2,717	3,212
Total Revenue	3,653	3,771	4,707	5,207	5,249	4,876	5,195	5,522	7,364	8,562
Operating Revenue	3,653	3,771	4,707	5,207	5,249	4,876	5,195	5,522	7,364	8,562
Total Cost of Revenue	2,249	2,309	2,860	3,181	3,203	3,046	3,220	3,438	4,647	5,350
Operating Cost of Revenue	2,249	2,309	2,860	3,181	3,203	3,046	3,220	3,438	4,647	5,350
Total Operating Expenses	955	1,054	1,295	1,372	1,560	1,463	1,390	1,462	2,065	2,203
Selling, General & Admin Expense	854	914	1,089	1,161	1,158	1,143	1,179	1,227	1,757	1,911
Research & Development Expense	95	110	181	189	191	187	204	206	232	230
Impairment Charge	-	-	0.00	22	211	133	7.00	29	76	62
Other Special Charges / (Income)	-	-	-	-	-	0.00	0.00	-	0.00	0.00
Total Other Income / (Expense), net	-46	-68	-86	-69	-70	-82	-74	-182	-17	78
Interest Expense	55	70	82	82	67	77	76	50	49	44
Interest & Investment Income	-	-	-	-	-	-	-	0.00	0.00	152
Other Income / (Expense), net	9.00	2.00	-4.00	13	-3.00	-5.00	2.00	-132	32	-30
Income Tax Expense	63	80	136	36	15	31	84	85	26	197
Basic Earnings per Share	$1.88	$1.45	$1.84	$3.05	$2.23	$1.41	$2.37	$1.97	$2.81	$3.67
Weighted Average Basic Shares Outstanding	180.89M	179.11M	179.60M	179.78M	179.99M	180.12M	180.25M	180.22M	217.01M	242.58M
Diluted Earnings per Share	$1.87	$1.45	$1.83	$3.03	$2.21	$1.40	$2.35	$1.96	$2.79	$3.65
Weighted Average Diluted Shares Outstanding	181.74M	180.04M	180.90M	181.13M	181.20M	181.10M	181.53M	180.98M	218.18M	243.52M
Weighted Average Basic & Diluted Shares Outstanding	180.90M	179.30M	179.90M	180M	180.22M	180.36M	179.90M	180.28M	241.77M	243.05M
Cash Dividends to Common per Share	$0.56	$0.62	$0.72	$0.84	$0.96	$1.04	$1.12	$1.20	$1.32	$1.44

This table shows Xylem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	12	149	99	92	152	266	153	194	217	326	169
Consolidated Net Income / (Loss)	12	149	99	92	152	266	153	194	217	326	167
Net Income / (Loss) Continuing Operations	12	149	99	92	152	266	153	194	217	326	167
Total Pre-Tax Income	17	189	126	114	185	210	196	247	269	375	217
Total Operating Income	168	197	131	119	191	211	209	253	280	267	231
Total Gross Profit	524	573	546	651	764	756	752	819	784	857	768
Total Revenue	1,380	1,506	1,448	1,722	2,076	2,118	2,033	2,169	2,104	2,256	2,069
Operating Revenue	1,380	1,506	1,448	1,722	2,076	2,118	2,033	2,169	2,104	2,256	2,069
Total Cost of Revenue	856	933	902	1,071	1,312	1,362	1,281	1,350	1,320	1,399	1,301
Operating Cost of Revenue	856	933	902	1,071	1,312	1,362	1,281	1,350	1,320	1,399	1,301
Total Operating Expenses	356	376	415	532	573	545	543	566	504	590	537
Selling, General & Admin Expense	294	315	354	446	491	466	474	485	445	507	460
Research & Development Expense	47	54	53	58	61	60	59	58	55	58	56
Impairment Charge	15	7.00	8.00	28	21	19	10	23	4.00	25	21
Total Other Income / (Expense), net	-151	-8.00	-5.00	-5.00	-6.00	-1.00	-13	-6.00	-11	108	-14
Interest Expense	12	13	9.00	12	14	14	14	11	10	9.00	8.00
Other Income / (Expense), net	-139	5.00	4.00	7.00	8.00	13	1.00	5.00	-1.00	-35	-6.00
Income Tax Expense	5.00	40	27	22	33	-56	43	53	52	49	50
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	-	-	-	-	-2.00
Basic Earnings per Share	$0.07	$0.83	$0.55	$0.45	$0.63	$1.18	$0.63	$0.80	$0.89	$1.35	$0.69
Weighted Average Basic Shares Outstanding	180.22M	180.22M	180.40M	205.54M	240.87M	217.01M	241.85M	242.57M	242.93M	242.58M	243.11M
Diluted Earnings per Share	$0.07	$0.82	$0.54	$0.45	$0.63	$1.17	$0.63	$0.80	$0.89	$1.33	$0.69
Weighted Average Diluted Shares Outstanding	180.94M	180.98M	181.32M	206.74M	242.19M	218.18M	243.02M	243.54M	243.75M	243.52M	243.78M
Weighted Average Basic & Diluted Shares Outstanding	180.22M	180.28M	180.62M	240.83M	241.08M	241.77M	242.45M	242.89M	242.94M	243.05M	243.35M
Cash Dividends to Common per Share	$0.30	-	-	-	$0.33	-	-	-	$0.36	-	$0.40

This table details how cash moves in and out of Xylem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	17	-372	106	-118	428	1,151	-526	-405	75	102
Net Cash From Operating Activities	464	497	686	586	839	824	538	596	837	1,263
Net Cash From Continuing Operating Activities	464	497	686	586	839	824	538	596	837	1,263
Net Income / (Loss) Continuing Operations	340	260	330	549	401	254	427	355	609	890
Consolidated Net Income / (Loss)	340	260	330	549	401	254	427	355	609	890
Depreciation Expense	88	87	109	117	117	117	118	111	193	258
Amortization Expense	45	64	125	144	140	134	127	125	243	304
Non-Cash Adjustments To Reconcile Net Income	-1.00	27	42	20	229	178	17	182	112	-9.00
Changes in Operating Assets and Liabilities, net	-8.00	59	80	-244	-48	141	-151	-177	-320	-180
Net Cash From Investing Activities	-132	-1,886	-181	-643	-231	-169	-183	-191	-628	-482
Net Cash From Continuing Investing Activities	-132	-1,886	-181	-643	-231	-169	-183	-191	-628	-482
Purchase of Property, Plant & Equipment	-117	-124	-170	-237	-226	-183	-208	-208	-271	-321
Acquisitions	-18	-1,782	-33	-433	-18	-	-5.00	-3.00	-533	-199
Purchase of Investments	0.00	0.00	-11	-11	-7.00	-200	0.00	-21	-1.00	-11
Sale of Property, Plant & Equipment	0.00	1.00	1.00	-	-	-	3.00	4.00	1.00	4.00
Divestitures	1.00	0.00	16	22	0.00	0.00	10	1.00	105	11
Sale and/or Maturity of Investments	0.00	0.00	10	11	20	212	14	33	29	35
Other Investing Activities, net	2.00	19	6.00	5.00	0.00	2.00	3.00	3.00	42	-1.00
Net Cash From Financing Activities	-262	1,034	-421	-40	-177	473	-855	-790	-157	-615
Net Cash From Continuing Financing Activities	-262	1,034	-421	-40	-177	473	-855	-790	-157	-615
Repayment of Debt	-4.00	-688	-282	-172	-257	-642	-603	-529	-173	-313
Repurchase of Common Equity	-179	-4.00	-25	-59	-40	-61	-68	-52	-25	-20
Payment of Dividends	-102	-112	-130	-152	-174	-188	-203	-217	-299	-350
Issuance of Debt	0.00	1,814	0.00	336	281	1,344	0.00	0.00	278	1.00
Other Financing Activities, net	23	24	16	7.00	13	20	19	8.00	62	67
Effect of Exchange Rate Changes	-53	-17	22	-21	-3.00	23	-26	-20	23	-53
Cash Interest Paid	52	49	78	78	77	77	99	76	69	67
Cash Income Taxes Paid	75	78	57	75	107	41	83	91	211	219

This table details how cash moves in and out of Xylem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	73	-242	-107	-129	-3.00	314	-72	-132	174	132	-62
Net Cash From Operating Activities	202	362	-19	28	373	455	89	288	311	575	33
Net Cash From Continuing Operating Activities	202	362	-19	28	373	455	89	288	311	575	33
Net Income / (Loss) Continuing Operations	12	149	99	92	152	266	153	194	217	326	169
Consolidated Net Income / (Loss)	12	149	99	92	152	266	153	194	217	326	169
Depreciation Expense	27	28	28	41	63	61	61	62	68	67	68
Amortization Expense	31	32	32	51	84	76	73	83	73	75	77
Non-Cash Adjustments To Reconcile Net Income	150	2.00	23	35	24	30	31	33	18	-91	54
Changes in Operating Assets and Liabilities, net	-18	151	-201	-191	50	22	-229	-84	-65	198	-335
Net Cash From Investing Activities	-39	-68	-37	-452	-50	-89	-51	-77	-65	-289	-15
Net Cash From Continuing Investing Activities	-39	-68	-37	-452	-50	-89	-51	-77	-65	-289	-15
Purchase of Property, Plant & Equipment	-53	-60	-49	-54	-74	-94	-74	-73	-74	-100	-71
Acquisitions	-1.00	-1.00	-	-	-2.00	1.00	-	-	-2.00	-190	-8.00
Purchase of Investments	-2.00	-12	0.00	-	-1.00	-	-2.00	-5.00	-1.00	-3.00	0.00
Sale of Property, Plant & Equipment	-	1.00	0.00	-	2.00	-1.00	1.00	2.00	-	1.00	5.00
Divestitures	-	-	0.00	91	12	2.00	11	-	-	-	48
Sale and/or Maturity of Investments	14	4.00	13	1.00	12	3.00	13	5.00	12	5.00	12
Other Investing Activities, net	3.00	-	-1.00	42	1.00	-	0.00	1.00	-	-2.00	-1.00
Net Cash From Financing Activities	-52	-580	-63	298	-306	-86	-82	-337	-101	-95	-116
Net Cash From Continuing Financing Activities	-52	-580	-63	298	-306	-86	-82	-337	-101	-95	-116
Repayment of Debt	-2.00	-528	-2.00	-4.00	-157	-10	-12	-277	-15	-9.00	-12
Repurchase of Common Equity	-	-	-8.00	-1.00	-1.00	-15	-15	-3.00	-1.00	-1.00	-13
Payment of Dividends	-53	-54	-60	-79	-80	-80	-88	-87	-88	-87	-98
Issuance of Debt	-	-	-	-	-73	2.00	-	-	-	1.00	1.00
Other Financing Activities, net	3.00	2.00	7.00	33	5.00	17	33	30	3.00	1.00	6.00
Effect of Exchange Rate Changes	-38	44	12	-3.00	-20	34	-28	-6.00	29	-48	25
Other Net Changes in Cash	-	-	-	-	-	-	-	-	-	-	11
Cash Interest Paid	27	9.00	11	19	13	26	13	23	13	18	12
Cash Income Taxes Paid	15	34	49	86	24	52	39	71	50	59	37

This table presents Xylem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	4,657	6,474	6,860	7,222	7,710	8,750	8,276	7,952	16,112	16,493
Total Current Assets	2,005	1,839	2,071	2,094	2,450	3,523	3,160	3,012	3,884	4,098
Cash & Equivalents	680	308	414	296	724	1,875	1,349	944	1,019	1,121
Accounts Receivable	749	843	956	1,031	1,036	923	953	1,096	1,617	1,668
Inventories, net	433	522	524	595	539	558	700	799	1,018	996
Prepaid Expenses	143	166	177	172	151	167	158	173	230	236
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	0.00	77
Plant, Property, & Equipment, net	439	616	643	656	658	657	644	630	1,169	1,152
Total Noncurrent Assets	2,213	4,019	4,146	4,472	4,602	4,570	4,472	4,310	11,059	11,243
Goodwill	1,584	2,632	2,768	2,976	2,839	2,854	2,792	2,719	7,587	7,980
Intangible Assets	435	1,201	1,168	1,232	1,174	1,093	1,016	930	2,529	2,379
Other Noncurrent Operating Assets	194	186	210	264	589	623	664	661	943	884
Total Liabilities & Shareholders' Equity	4,657	6,474	6,860	7,222	7,710	8,750	8,276	7,952	16,112	16,493
Total Liabilities	2,573	4,267	4,341	4,440	4,743	5,774	5,050	4,449	5,936	5,611
Total Current Liabilities	823	1,238	1,100	1,389	1,501	1,956	1,391	1,590	2,205	2,336
Short-Term Debt	78	260	0.00	257	276	600	-	0.00	16	38
Accounts Payable	338	457	549	586	597	569	639	723	968	1,006
Accrued Expenses	407	521	551	546	628	787	752	867	1,221	1,271
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	0.00	21
Total Noncurrent Liabilities	1,750	3,029	3,241	3,051	3,242	3,818	3,659	2,859	3,731	3,275
Long-Term Debt	1,196	2,108	2,200	2,051	2,040	2,484	2,440	1,880	2,268	1,978
Noncurrent Deferred & Payable Income Tax Liabilities	118	352	252	303	310	242	287	222	557	497
Noncurrent Employee Benefit Liabilities	335	408	442	400	445	519	438	286	344	304
Other Noncurrent Operating Liabilities	101	161	347	297	447	573	494	471	562	496
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	-	0.00	235
Total Equity & Noncontrolling Interests	2,084	2,207	2,519	2,782	2,967	2,976	3,226	3,503	10,176	10,647
Total Preferred & Common Equity	2,084	2,190	2,503	2,768	2,957	2,968	3,218	3,494	10,166	10,642
Total Common Equity	2,084	2,190	2,503	2,768	2,957	2,968	3,218	3,494	10,166	10,642
Common Stock	1,836	1,878	1,914	1,952	1,993	2,039	2,091	2,136	8,567	8,690
Retained Earnings	885	1,033	1,227	1,639	1,866	1,930	2,154	2,292	2,601	3,140
Treasury Stock	-399	-403	-428	-487	-527	-588	-656	-708	-733	-753
Accumulated Other Comprehensive Income / (Loss)	-238	-318	-210	-336	-375	-413	-371	-226	-269	-435
Noncontrolling Interest	0.00	17	16	14	10	8.00	8.00	9.00	10	5.00

This table presents Xylem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Total Assets	8,106	7,952	7,940	16,097	15,905	16,112	15,924	15,765	16,046	16,493	16,559
Total Current Assets	3,191	3,012	3,010	3,735	3,651	3,884	3,893	3,781	4,013	4,098	4,084
Cash & Equivalents	1,186	944	837	708	705	1,019	947	815	989	1,121	1,059
Accounts Receivable	1,018	1,096	1,123	1,659	1,653	1,617	1,641	1,675	1,707	1,668	1,743
Inventories, net	837	799	857	1,143	1,080	1,018	1,039	1,057	1,091	996	1,022
Prepaid Expenses	150	173	193	225	213	230	266	234	226	236	260
Other Current Nonoperating Assets	-	-	-	-	-	0.00	-	-	-	77	0.00
Plant, Property, & Equipment, net	585	630	631	1,144	1,132	1,169	1,141	1,144	1,158	1,152	1,157
Total Noncurrent Assets	4,330	4,310	4,299	11,218	11,122	11,059	10,890	10,840	10,875	11,243	11,318
Goodwill	2,637	2,719	2,738	7,108	7,149	7,587	7,509	7,509	7,593	7,980	8,061
Intangible Assets	933	930	915	3,188	3,039	2,529	2,454	2,374	2,326	2,379	2,332
Other Noncurrent Operating Assets	760	661	646	922	934	943	927	957	956	884	925
Total Liabilities & Shareholders' Equity	8,106	7,952	7,940	16,097	15,905	16,112	15,924	15,765	16,046	16,493	16,559
Total Liabilities	4,884	4,449	4,351	6,187	5,964	5,936	5,721	5,417	5,446	5,611	5,505
Total Current Liabilities	1,929	1,590	1,494	2,282	2,120	2,205	2,331	2,042	2,052	2,336	2,166
Short-Term Debt	483	0.00	0.00	240	17	16	285	17	17	38	41
Accounts Payable	618	723	710	968	943	968	948	940	930	1,006	958
Accrued Expenses	828	867	784	1,074	1,160	1,221	1,098	1,085	1,105	1,271	1,167
Other Current Nonoperating Liabilities	-	-	-	-	-	0.00	-	-	-	21	0.00
Total Noncurrent Liabilities	2,955	2,859	2,857	3,905	3,844	3,731	3,390	3,375	3,394	3,275	3,339
Long-Term Debt	1,880	1,880	1,881	2,267	2,253	2,268	1,985	1,981	1,977	1,978	1,974
Noncurrent Deferred & Payable Income Tax Liabilities	260	222	215	738	724	557	558	552	535	497	486
Noncurrent Employee Benefit Liabilities	361	286	285	293	281	344	323	325	332	304	317
Other Noncurrent Operating Liabilities	454	471	476	607	586	562	524	517	550	496	562
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	0.00	-	-	-	235	232
Total Equity & Noncontrolling Interests	3,222	3,503	3,589	9,910	9,941	10,176	10,203	10,348	10,600	10,647	10,822
Total Preferred & Common Equity	3,215	3,494	3,578	9,899	9,930	10,166	10,195	10,341	10,593	10,642	10,816
Total Common Equity	3,215	3,494	3,578	9,899	9,930	10,166	10,195	10,341	10,593	10,642	10,816
Common Stock	2,125	2,136	2,154	8,498	8,532	8,567	8,621	8,663	8,676	8,690	8,708
Retained Earnings	2,197	2,292	2,331	2,344	2,416	2,601	2,667	2,774	2,902	3,140	3,211
Treasury Stock	-708	-708	-716	-717	-718	-733	-748	-751	-753	-753	-766
Accumulated Other Comprehensive Income / (Loss)	-399	-226	-191	-226	-300	-269	-345	-345	-232	-435	-337
Noncontrolling Interest	7.00	9.00	11	11	11	10	8.00	7.00	7.00	5.00	6.00

This table displays calculated financial ratios and metrics derived from Xylem's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.72%	3.23%	24.82%	10.62%	0.81%	-7.11%	6.54%	6.29%	33.36%	16.27%
EBITDA Growth	-4.21%	-5.08%	39.39%	18.67%	-20.26%	-17.16%	35.73%	-12.74%	54.27%	37.59%
EBIT Growth	-3.58%	-10.48%	33.66%	21.72%	-27.59%	-25.05%	62.15%	-16.52%	39.59%	43.13%
NOPAT Growth	2.21%	-17.64%	25.29%	57.01%	-23.67%	-30.18%	49.45%	2.66%	24.60%	32.12%
Net Income Growth	0.89%	-23.53%	26.92%	66.36%	-26.96%	-36.66%	68.11%	-16.86%	71.55%	46.14%
EPS Growth	2.19%	-22.46%	26.21%	65.57%	-27.06%	-36.65%	67.86%	-16.60%	42.35%	30.82%
Operating Cash Flow Growth	11.54%	7.11%	38.03%	-14.58%	43.17%	-1.79%	-34.71%	10.78%	40.44%	50.90%
Free Cash Flow Firm Growth	-21.48%	-384.53%	127.64%	-64.65%	463.89%	-0.34%	-49.10%	6.45%	-1,778.78%	108.56%
Invested Capital Growth	-2.55%	59.34%	0.89%	11.36%	-4.90%	-8.20%	3.15%	2.83%	157.74%	2.45%
Revenue Q/Q Growth	-1.30%	2.75%	4.02%	2.14%	-0.29%	0.04%	-0.95%	3.43%	9.06%	1.64%
EBITDA Q/Q Growth	-0.51%	-1.58%	8.31%	4.50%	-0.80%	-2.70%	-4.91%	9.67%	9.70%	0.85%
EBIT Q/Q Growth	0.22%	-7.24%	10.93%	5.37%	-1.02%	-3.72%	-6.38%	14.75%	3.32%	0.82%
NOPAT Q/Q Growth	5.83%	-17.08%	6.90%	34.50%	-20.71%	16.28%	-7.93%	4.97%	22.31%	-3.70%
Net Income Q/Q Growth	5.59%	-19.75%	6.45%	39.34%	-21.06%	13.39%	-7.58%	11.29%	23.78%	7.23%
EPS Q/Q Growth	6.86%	-19.44%	6.40%	38.99%	-21.07%	13.82%	-7.84%	11.36%	14.34%	4.58%
Operating Cash Flow Q/Q Growth	9.69%	3.97%	13.95%	-15.68%	29.28%	-2.14%	-21.80%	31.28%	12.50%	10.50%
Free Cash Flow Firm Q/Q Growth	-19.13%	-518.30%	126.35%	-31.20%	23.24%	1.12%	-40.02%	-0.32%	3.32%	-28.04%
Invested Capital Q/Q Growth	-1.07%	53.60%	-3.97%	0.76%	-4.58%	-4.15%	0.35%	0.91%	-0.56%	1.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	38.43%	38.77%	39.24%	38.91%	38.98%	37.53%	38.02%	37.74%	36.90%	37.51%
EBITDA Margin	16.18%	14.88%	16.61%	17.82%	14.10%	12.57%	16.02%	13.15%	15.21%	18.00%
Operating Margin	12.29%	10.82%	11.73%	12.56%	9.26%	7.53%	11.26%	11.26%	8.85%	11.78%
EBIT Margin	12.54%	10.87%	11.64%	12.81%	9.20%	7.42%	11.30%	8.87%	9.29%	11.43%
Profit (Net Income) Margin	9.31%	6.89%	7.01%	10.54%	7.64%	5.21%	8.22%	6.43%	8.27%	10.39%
Tax Burden Percent	84.37%	76.47%	70.82%	93.85%	96.39%	89.12%	83.56%	80.68%	95.91%	81.88%
Interest Burden Percent	87.99%	82.93%	85.04%	87.71%	86.13%	78.73%	87.05%	89.80%	92.84%	111.03%
Effective Tax Rate	15.63%	23.53%	29.18%	6.15%	3.61%	10.88%	16.44%	19.32%	4.09%	18.12%
Return on Invested Capital (ROIC)	13.96%	8.98%	9.12%	13.49%	10.02%	7.48%	11.50%	11.46%	7.88%	7.13%
ROIC Less NNEP Spread (ROIC-NNEP)	7.57%	5.07%	5.95%	10.08%	6.27%	2.26%	6.12%	-3.03%	6.39%	13.20%
Return on Net Nonoperating Assets (RNNOA)	2.19%	3.13%	4.84%	7.22%	3.93%	1.07%	2.27%	-0.91%	1.03%	1.32%
Return on Equity (ROE)	16.15%	12.12%	13.97%	20.71%	13.95%	8.55%	13.77%	10.55%	8.90%	8.45%
Cash Return on Invested Capital (CROIC)	16.54%	-36.77%	8.23%	2.74%	15.04%	16.04%	8.39%	8.68%	-80.31%	4.72%
Operating Return on Assets (OROA)	9.65%	7.37%	8.22%	9.47%	6.47%	4.40%	6.90%	6.04%	5.68%	6.01%
Return on Assets (ROA)	7.17%	4.67%	4.95%	7.80%	5.37%	3.09%	5.02%	4.38%	5.06%	5.46%
Return on Common Equity (ROCE)	16.15%	12.07%	13.87%	20.60%	13.89%	8.52%	13.73%	10.52%	8.89%	8.35%
Return on Equity Simple (ROE_SIMPLE)	16.31%	11.87%	13.18%	19.83%	13.56%	8.56%	13.27%	10.16%	5.99%	8.36%
Net Operating Profit after Tax (NOPAT)	379	312	391	614	468	327	489	502	625	826
NOPAT Margin	10.37%	8.27%	8.30%	11.79%	8.93%	6.71%	9.41%	9.09%	8.49%	9.65%
Net Nonoperating Expense Percent (NNEP)	6.39%	3.92%	3.17%	3.41%	3.74%	5.22%	5.38%	14.49%	1.48%	-6.07%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.32%	5.02%	6.52%
Cost of Revenue to Revenue	61.57%	61.23%	60.76%	61.09%	61.02%	62.47%	61.98%	62.26%	63.10%	62.49%
SG&A Expenses to Revenue	23.38%	24.24%	23.14%	22.30%	22.06%	23.44%	22.69%	22.22%	23.86%	22.32%
R&D to Revenue	2.60%	2.92%	3.85%	3.63%	3.64%	3.84%	3.93%	3.73%	3.15%	2.69%
Operating Expenses to Revenue	26.14%	27.95%	27.51%	26.35%	29.72%	30.00%	26.76%	26.48%	28.04%	25.73%
Earnings before Interest and Taxes (EBIT)	458	410	548	667	483	362	587	490	684	979
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	591	561	782	928	740	613	832	726	1,120	1,541
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.83	3.70	4.52	4.05	4.55	5.93	6.51	5.55	2.67	2.64
Price to Tangible Book Value (P/TBV)	90.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	543.69	99.29
Price to Revenue (P/Rev)	1.61	2.15	2.41	2.15	2.56	3.61	4.03	3.51	3.69	3.28
Price to Earnings (P/E)	17.33	31.19	34.21	20.43	33.52	69.34	49.08	54.64	44.64	31.57
Dividend Yield	1.71%	1.37%	1.14%	1.35%	1.29%	1.06%	0.96%	1.12%	1.17%	1.25%
Earnings Yield	5.77%	3.21%	2.92%	4.89%	2.98%	1.44%	2.04%	1.83%	2.24%	3.17%
Enterprise Value to Invested Capital (EV/IC)	2.42	2.39	3.05	2.76	3.30	4.50	5.11	4.58	2.49	2.49
Enterprise Value to Revenue (EV/Rev)	1.78	2.70	2.79	2.54	2.87	3.86	4.25	3.68	3.86	3.41
Enterprise Value to EBITDA (EV/EBITDA)	10.98	18.16	16.79	14.27	20.33	30.71	26.51	28.02	25.41	18.97
Enterprise Value to EBIT (EV/EBIT)	14.16	24.84	23.95	19.86	31.15	52.01	37.57	41.51	41.61	29.86
Enterprise Value to NOPAT (EV/NOPAT)	17.12	32.65	33.58	21.58	32.11	57.56	45.12	40.53	45.51	35.39
Enterprise Value to Operating Cash Flow (EV/OCF)	13.98	20.49	19.14	22.60	17.93	22.85	41.00	34.13	34.00	23.15
Enterprise Value to Free Cash Flow (EV/FCFF)	14.45	0.00	37.20	106.16	21.39	26.86	61.81	53.55	0.00	53.53
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.61	1.07	0.87	0.83	0.78	1.04	0.76	0.54	0.22	0.19
Long-Term Debt to Equity	0.57	0.96	0.87	0.74	0.69	0.83	0.76	0.54	0.22	0.18
Financial Leverage	0.29	0.62	0.81	0.72	0.63	0.47	0.37	0.30	0.16	0.10
Leverage Ratio	2.25	2.59	2.82	2.66	2.60	2.77	2.75	2.41	1.76	1.55
Compound Leverage Factor	1.98	2.15	2.40	2.33	2.24	2.18	2.39	2.17	1.63	1.72
Debt to Total Capital	37.94%	51.76%	46.62%	45.34%	43.84%	50.89%	43.06%	34.92%	18.33%	15.63%
Short-Term Debt to Total Capital	2.32%	5.68%	0.00%	5.05%	5.22%	9.90%	0.00%	0.00%	0.13%	0.29%
Long-Term Debt to Total Capital	35.62%	46.08%	46.62%	40.29%	38.61%	40.99%	43.06%	34.92%	18.20%	15.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.37%	0.34%	0.28%	0.19%	0.13%	0.14%	0.17%	0.08%	1.86%
Common Equity to Total Capital	62.06%	47.87%	53.04%	54.38%	55.97%	48.98%	56.79%	64.91%	81.59%	82.51%
Debt to EBITDA	2.16	4.22	2.81	2.49	3.13	5.03	2.93	2.59	2.04	1.31
Net Debt to EBITDA	1.01	3.67	2.28	2.17	2.15	1.97	1.31	1.29	1.13	0.58
Long-Term Debt to EBITDA	2.02	3.76	2.81	2.21	2.76	4.05	2.93	2.59	2.03	1.28
Debt to NOPAT	3.36	7.59	5.63	3.76	4.94	9.43	4.99	3.75	3.65	2.44
Net Debt to NOPAT	1.57	6.60	4.57	3.28	3.40	3.70	2.23	1.87	2.02	1.08
Long-Term Debt to NOPAT	3.16	6.76	5.63	3.34	4.35	7.59	4.99	3.75	3.63	2.39
Altman Z-Score	3.05	2.27	2.94	2.98	3.07	3.05	3.97	4.13	3.70	4.11
Noncontrolling Interest Sharing Ratio	0.00%	0.40%	0.70%	0.57%	0.42%	0.30%	0.26%	0.25%	0.14%	1.19%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.44	1.49	1.88	1.51	1.63	1.80	2.27	1.89	1.76	1.75
Quick Ratio	1.74	0.93	1.25	0.96	1.17	1.43	1.65	1.28	1.20	1.19
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	449	-1,277	353	125	703	701	357	380	-6,377	546
Operating Cash Flow to CapEx	396.58%	404.07%	405.92%	247.26%	371.24%	450.27%	262.44%	292.16%	310.00%	398.42%
Free Cash Flow to Firm to Interest Expense	8.16	-18.24	4.30	1.52	10.50	9.10	4.70	7.60	-130.14	12.41
Operating Cash Flow to Interest Expense	8.44	7.10	8.37	7.15	12.52	10.70	7.08	11.92	17.08	28.70
Operating Cash Flow Less CapEx to Interest Expense	6.31	5.34	6.30	4.26	9.15	8.32	4.38	7.84	11.57	21.50
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.77	0.68	0.71	0.74	0.70	0.59	0.61	0.68	0.61	0.53
Accounts Receivable Turnover	4.81	4.74	5.23	5.24	5.08	4.98	5.54	5.39	5.43	5.21
Inventory Turnover	4.89	4.84	5.47	5.69	5.65	5.55	5.12	4.59	5.12	5.31
Fixed Asset Turnover	8.12	7.15	7.48	8.02	7.99	7.42	7.99	8.67	8.19	7.38
Accounts Payable Turnover	6.65	5.81	5.69	5.61	5.42	5.22	5.33	5.05	5.50	5.42
Days Sales Outstanding (DSO)	75.94	77.05	69.75	69.64	71.87	73.32	65.90	67.72	67.24	70.02
Days Inventory Outstanding (DIO)	74.57	75.48	66.75	64.20	64.61	65.73	71.30	79.57	71.36	68.70
Days Payable Outstanding (DPO)	54.86	62.84	64.19	65.12	67.40	69.86	68.47	72.30	66.41	67.34
Cash Conversion Cycle (CCC)	95.66	89.69	72.30	68.72	69.07	69.19	68.74	74.99	72.18	71.38
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,678	4,267	4,305	4,794	4,559	4,185	4,317	4,439	11,441	11,721
Invested Capital Turnover	1.35	1.09	1.10	1.14	1.12	1.12	1.22	1.26	0.93	0.74
Increase / (Decrease) in Invested Capital	-70	1,589	38	489	-235	-374	132	122	7,002	280
Enterprise Value (EV)	6,486	10,186	13,127	13,244	15,044	18,828	22,056	20,341	28,459	29,234
Market Capitalization	5,892	8,109	11,325	11,218	13,442	17,611	20,957	19,396	27,184	28,099
Book Value per Share	$11.62	$12.21	$13.94	$15.40	$16.42	$16.47	$17.85	$19.39	$42.17	$43.80
Tangible Book Value per Share	$0.36	($9.16)	($7.98)	($8.01)	($5.86)	($5.43)	($3.27)	($0.86)	$0.21	$1.16
Total Capital	3,358	4,575	4,719	5,090	5,283	6,060	5,666	5,383	12,460	12,898
Total Debt	1,274	2,368	2,200	2,308	2,316	3,084	2,440	1,880	2,284	2,016
Total Long-Term Debt	1,196	2,108	2,200	2,051	2,040	2,484	2,440	1,880	2,268	1,978
Net Debt	594	2,060	1,786	2,012	1,592	1,209	1,091	936	1,265	895
Capital Expenditures (CapEx)	117	123	169	237	226	183	205	204	270	317
Debt-free, Cash-free Net Working Capital (DFCFNWC)	580	553	557	666	501	292	420	478	676	679
Debt-free Net Working Capital (DFNWC)	1,260	861	971	962	1,225	2,167	1,769	1,422	1,695	1,800
Net Working Capital (NWC)	1,182	601	971	705	949	1,567	1,769	1,422	1,679	1,762
Net Nonoperating Expense (NNE)	39	52	61	65	67	73	62	147	16	-64
Net Nonoperating Obligations (NNO)	594	2,060	1,786	2,012	1,592	1,209	1,091	936	1,265	839
Total Depreciation and Amortization (D&A)	133	151	234	261	257	251	245	236	436	562
Debt-free, Cash-free Net Working Capital to Revenue	15.88%	14.66%	11.83%	12.79%	9.54%	5.99%	8.08%	8.66%	9.18%	7.93%
Debt-free Net Working Capital to Revenue	34.49%	22.83%	20.63%	18.48%	23.34%	44.44%	34.05%	25.75%	23.02%	21.02%
Net Working Capital to Revenue	32.36%	15.94%	20.63%	13.54%	18.08%	32.14%	34.05%	25.75%	22.80%	20.58%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.88	$1.45	$1.84	$3.05	$2.23	$1.41	$2.37	$1.97	$2.81	$3.67
Adjusted Weighted Average Basic Shares Outstanding	180.89M	179.11M	179.63M	179.78M	180M	180.12M	180.25M	180.22M	217.01M	242.58M
Adjusted Diluted Earnings per Share	$1.87	$1.45	$1.83	$3.03	$2.21	$1.40	$2.35	$1.96	$2.79	$3.65
Adjusted Weighted Average Diluted Shares Outstanding	181.74M	180.04M	180.86M	181.13M	181.20M	181.10M	181.53M	180.98M	218.18M	243.52M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	178.49M	179.47M	179.89M	179.55M	180.22M	180.36M	179.90M	180.28M	241.77M	243.05M
Normalized Net Operating Profit after Tax (NOPAT)	384	335	409	634	672	446	495	525	698	877
Normalized NOPAT Margin	10.51%	8.88%	8.68%	12.18%	12.80%	9.14%	9.52%	9.51%	9.48%	10.24%
Pre Tax Income Margin	11.03%	9.02%	9.90%	11.23%	7.93%	5.85%	9.84%	7.97%	8.62%	12.70%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.33	5.86	6.68	8.13	7.21	4.70	7.72	9.80	13.96	22.25
NOPAT to Interest Expense	6.89	4.46	4.77	7.48	6.99	4.25	6.43	10.04	12.76	18.78
EBIT Less CapEx to Interest Expense	6.20	4.10	4.62	5.24	3.84	2.32	5.03	5.72	8.45	15.05
NOPAT Less CapEx to Interest Expense	4.76	2.70	2.71	4.59	3.62	1.87	3.73	5.96	7.25	11.57
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	30.00%	43.08%	39.39%	27.69%	43.39%	74.02%	47.54%	61.13%	49.10%	39.33%
Augmented Payout Ratio	82.65%	44.62%	46.97%	38.43%	53.37%	98.03%	63.47%	75.77%	53.20%	41.57%

This table displays calculated financial ratios and metrics derived from Xylem's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.09%	13.83%	13.84%	26.25%	50.43%	40.64%	40.40%	25.96%	1.35%	6.52%	1.77%
EBITDA Growth	-59.72%	32.32%	15.38%	4.81%	297.70%	37.79%	76.41%	84.86%	21.39%	3.60%	7.56%
EBIT Growth	-81.17%	45.32%	21.62%	-14.86%	586.21%	10.89%	55.56%	104.76%	40.20%	3.57%	7.14%
NOPAT Growth	-8.98%	23.70%	10.82%	-20.13%	32.33%	72.09%	58.51%	106.92%	43.93%	-13.15%	8.97%
Net Income Growth	-89.47%	31.86%	20.73%	-17.86%	1,166.67%	78.52%	54.55%	110.87%	42.76%	22.56%	9.15%
EPS Growth	-88.89%	32.26%	20.00%	-27.42%	800.00%	42.68%	16.67%	77.78%	41.27%	13.68%	9.52%
Operating Cash Flow Growth	80.36%	64.55%	76.54%	-75.22%	84.65%	25.69%	568.42%	928.57%	-16.62%	26.37%	-62.92%
Free Cash Flow Firm Growth	-88.89%	616.83%	92.74%	-7,416.47%	-32,293.79%	-20,320.25%	-83,278.70%	105.29%	101.83%	99.29%	95.45%
Invested Capital Growth	2.25%	2.83%	2.45%	160.78%	161.56%	157.74%	148.78%	-1.52%	0.86%	2.45%	4.20%
Revenue Q/Q Growth	1.17%	9.13%	-3.85%	18.92%	20.56%	2.02%	-4.01%	6.69%	-3.00%	7.22%	-8.29%
EBITDA Q/Q Growth	-58.17%	201.15%	-25.57%	11.79%	58.72%	4.34%	-4.71%	17.15%	4.22%	-10.95%	-1.07%
EBIT Q/Q Growth	-80.41%	596.55%	-33.17%	-6.67%	57.94%	12.56%	-6.25%	22.86%	8.14%	-16.85%	-3.02%
NOPAT Q/Q Growth	-1.37%	30.96%	-33.73%	-6.70%	63.41%	70.31%	-38.96%	21.80%	13.67%	2.76%	-23.41%
Net Income Q/Q Growth	-89.29%	1,141.67%	-33.56%	-7.07%	65.22%	75.00%	-42.48%	26.80%	11.86%	50.23%	-48.77%
EPS Q/Q Growth	-88.71%	1,071.43%	-34.15%	-16.67%	40.00%	85.71%	-46.15%	26.98%	11.25%	49.44%	-48.12%
Operating Cash Flow Q/Q Growth	78.76%	79.21%	-105.25%	247.37%	1,232.14%	21.98%	-80.44%	223.60%	7.99%	84.89%	-94.26%
Free Cash Flow Firm Q/Q Growth	122.78%	54.28%	-124.23%	-88,149.12%	2.43%	3.10%	0.07%	105.60%	-66.32%	-137.74%	-539.46%
Invested Capital Q/Q Growth	-2.03%	0.91%	4.37%	152.73%	-1.73%	-0.56%	0.74%	0.04%	0.64%	1.00%	2.47%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.97%	38.05%	37.71%	37.80%	36.80%	35.69%	36.99%	37.76%	37.26%	37.99%	37.12%
EBITDA Margin	6.30%	17.40%	13.47%	12.66%	16.67%	17.04%	16.92%	18.58%	19.96%	16.58%	17.88%
Operating Margin	12.17%	13.08%	9.05%	6.91%	9.20%	9.96%	10.28%	11.66%	13.31%	11.84%	11.16%
EBIT Margin	2.10%	13.41%	9.32%	7.32%	9.59%	10.58%	10.33%	11.89%	13.26%	10.28%	10.87%
Profit (Net Income) Margin	0.87%	9.89%	6.84%	5.34%	7.32%	12.56%	7.53%	8.94%	10.31%	14.45%	8.07%
Tax Burden Percent	70.59%	78.84%	78.57%	80.70%	82.16%	126.67%	78.06%	78.54%	80.67%	86.93%	76.96%
Interest Burden Percent	58.62%	93.56%	93.33%	90.48%	92.96%	93.75%	93.33%	95.74%	96.42%	161.64%	96.44%
Effective Tax Rate	29.41%	21.16%	21.43%	19.30%	17.84%	-26.67%	21.94%	21.46%	19.33%	13.07%	23.04%
Return on Invested Capital (ROIC)	10.55%	13.01%	8.85%	4.17%	6.42%	11.70%	7.90%	6.62%	7.83%	7.61%	6.28%
ROIC Less NNEP Spread (ROIC-NNEP)	1.58%	12.39%	8.52%	3.91%	6.06%	11.59%	7.04%	6.30%	7.14%	16.53%	5.33%
Return on Net Nonoperating Assets (RNNOA)	0.59%	3.73%	2.96%	0.92%	1.26%	1.86%	1.21%	0.93%	0.89%	1.65%	0.57%
Return on Equity (ROE)	11.14%	16.74%	11.81%	5.09%	7.68%	13.57%	9.10%	7.55%	8.72%	9.26%	6.85%
Cash Return on Invested Capital (CROIC)	8.76%	8.68%	8.72%	-83.14%	-82.94%	-80.31%	-76.82%	8.32%	6.57%	4.72%	3.04%
Operating Return on Assets (OROA)	1.38%	9.13%	6.58%	3.65%	5.39%	6.47%	6.88%	6.27%	6.99%	5.40%	5.76%
Return on Assets (ROA)	0.57%	6.73%	4.82%	2.66%	4.12%	7.69%	5.01%	4.71%	5.44%	7.59%	4.27%
Return on Common Equity (ROCE)	11.11%	16.70%	11.77%	5.08%	7.67%	13.55%	9.09%	7.54%	8.71%	9.15%	6.77%
Return on Equity Simple (ROE_SIMPLE)	9.92%	0.00%	10.40%	3.56%	4.95%	0.00%	6.50%	7.40%	7.84%	0.00%	8.36%
Net Operating Profit after Tax (NOPAT)	119	155	103	96	157	267	163	199	226	232	178
NOPAT Margin	8.59%	10.31%	7.11%	5.58%	7.56%	12.62%	8.03%	9.16%	10.74%	10.29%	8.59%
Net Nonoperating Expense Percent (NNEP)	8.97%	0.62%	0.33%	0.26%	0.36%	0.12%	0.86%	0.32%	0.69%	-8.92%	0.95%
Return On Investment Capital (ROIC_SIMPLE)	-	2.89%	-	-	-	2.15%	-	-	-	1.83%	1.38%
Cost of Revenue to Revenue	62.03%	61.95%	62.29%	62.20%	63.20%	64.31%	63.01%	62.24%	62.74%	62.01%	62.88%
SG&A Expenses to Revenue	21.30%	20.92%	24.45%	25.90%	23.65%	22.00%	23.32%	22.36%	21.15%	22.47%	22.23%
R&D to Revenue	3.41%	3.59%	3.66%	3.37%	2.94%	2.83%	2.90%	2.67%	2.61%	2.57%	2.71%
Operating Expenses to Revenue	25.80%	24.97%	28.66%	30.89%	27.60%	25.73%	26.71%	26.10%	23.95%	26.15%	25.95%
Earnings before Interest and Taxes (EBIT)	29	202	135	126	199	224	210	258	279	232	225
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	87	262	195	218	346	361	344	403	420	374	370
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.79	5.55	5.19	2.03	2.18	2.67	3.05	3.18	3.10	2.64	2.68
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	543.69	133.95	71.80	48.66	99.29	68.64
Price to Revenue (P/Rev)	2.89	3.51	3.26	3.32	3.21	3.69	3.91	3.92	3.89	3.28	3.38
Price to Earnings (P/E)	48.31	54.64	49.97	57.10	44.05	44.64	46.87	42.98	39.52	31.57	32.05
Dividend Yield	1.38%	1.12%	1.19%	1.13%	1.43%	1.17%	1.05%	1.02%	1.04%	1.25%	1.24%
Earnings Yield	2.07%	1.83%	2.00%	1.75%	2.27%	2.24%	2.13%	2.33%	2.53%	3.17%	3.12%
Enterprise Value to Invested Capital (EV/IC)	3.77	4.58	4.24	1.87	2.02	2.49	2.81	2.95	2.91	2.49	2.52
Enterprise Value to Revenue (EV/Rev)	3.11	3.68	3.45	3.62	3.44	3.86	4.08	4.06	4.01	3.41	3.52
Enterprise Value to EBITDA (EV/EBITDA)	25.07	28.02	26.12	28.75	22.77	25.41	25.54	23.43	22.13	18.97	19.29
Enterprise Value to EBIT (EV/EBIT)	38.87	41.51	38.21	44.53	35.12	41.61	42.70	38.24	34.82	29.86	30.41
Enterprise Value to NOPAT (EV/NOPAT)	34.71	40.53	38.49	45.14	45.48	45.51	47.20	43.20	39.41	35.39	35.94
Enterprise Value to Operating Cash Flow (EV/OCF)	36.55	34.13	29.85	38.23	31.25	34.00	34.29	28.28	29.58	23.15	25.04
Enterprise Value to Free Cash Flow (EV/FCFF)	43.55	53.55	49.19	0.00	0.00	0.00	0.00	35.25	44.55	53.53	84.63
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.73	0.54	0.52	0.25	0.23	0.22	0.22	0.19	0.19	0.19	0.18
Long-Term Debt to Equity	0.58	0.54	0.52	0.23	0.23	0.22	0.19	0.19	0.19	0.18	0.18
Financial Leverage	0.38	0.30	0.35	0.24	0.21	0.16	0.17	0.15	0.13	0.10	0.11
Leverage Ratio	2.57	2.41	2.38	1.85	1.82	1.76	1.73	1.57	1.56	1.55	1.53
Compound Leverage Factor	1.51	2.26	2.22	1.68	1.70	1.65	1.61	1.51	1.50	2.50	1.47
Debt to Total Capital	42.31%	34.92%	34.39%	20.19%	18.59%	18.33%	18.20%	16.18%	15.83%	15.63%	15.42%
Short-Term Debt to Total Capital	8.65%	0.00%	0.00%	1.93%	0.14%	0.13%	2.28%	0.14%	0.14%	0.29%	0.31%
Long-Term Debt to Total Capital	33.66%	34.92%	34.39%	18.26%	18.45%	18.20%	15.91%	16.05%	15.70%	15.34%	15.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.13%	0.17%	0.20%	0.09%	0.09%	0.08%	0.06%	0.06%	0.06%	1.86%	1.82%
Common Equity to Total Capital	57.56%	64.91%	65.41%	79.72%	81.32%	81.59%	81.74%	83.76%	84.11%	82.51%	82.76%
Debt to EBITDA	3.57	2.59	2.50	3.29	2.22	2.04	1.79	1.37	1.31	1.31	1.29
Net Debt to EBITDA	1.78	1.29	1.39	2.36	1.53	1.13	1.04	0.81	0.66	0.58	0.61
Long-Term Debt to EBITDA	2.84	2.59	2.50	2.98	2.21	2.03	1.56	1.36	1.29	1.28	1.26
Debt to NOPAT	4.94	3.75	3.69	5.17	4.44	3.65	3.31	2.53	2.32	2.44	2.40
Net Debt to NOPAT	2.46	1.87	2.05	3.71	3.06	2.02	1.93	1.50	1.17	1.08	1.14
Long-Term Debt to NOPAT	3.93	3.75	3.69	4.67	4.41	3.63	2.89	2.51	2.30	2.39	2.35
Altman Z-Score	3.13	4.01	3.98	2.66	2.97	3.60	4.15	4.61	4.60	3.97	4.14
Noncontrolling Interest Sharing Ratio	0.25%	0.25%	0.28%	0.14%	0.14%	0.14%	0.14%	0.09%	0.09%	1.19%	1.16%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.65	1.89	2.01	1.64	1.72	1.76	1.67	1.85	1.96	1.75	1.89
Quick Ratio	1.14	1.28	1.31	1.04	1.11	1.20	1.11	1.22	1.31	1.19	1.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	22	33	-8.07	-7,123	-6,950	-6,735	-6,730	377	127	-48	-306
Operating Cash Flow to CapEx	381.13%	613.56%	-38.78%	51.85%	518.06%	478.95%	121.92%	405.63%	420.27%	580.81%	50.00%
Free Cash Flow to Firm to Interest Expense	1.80	2.56	-0.90	-593.58	-496.43	-481.05	-480.70	34.25	12.69	-5.32	-38.28
Operating Cash Flow to Interest Expense	16.83	27.85	-2.11	2.33	26.64	32.50	6.36	26.18	31.10	63.89	4.13
Operating Cash Flow Less CapEx to Interest Expense	12.42	23.31	-7.56	-2.17	21.50	25.71	1.14	19.73	23.70	52.89	-4.13
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.66	0.68	0.71	0.50	0.56	0.61	0.67	0.53	0.53	0.53	0.53
Accounts Receivable Turnover	5.36	5.39	5.34	4.51	5.06	5.43	5.75	5.04	5.01	5.21	5.08
Inventory Turnover	4.40	4.59	4.26	3.77	4.40	5.12	5.30	4.82	4.89	5.31	5.21
Fixed Asset Turnover	8.88	8.67	8.99	6.91	7.86	8.19	8.97	7.34	7.36	7.38	7.48
Accounts Payable Turnover	5.58	5.05	5.19	4.66	5.40	5.50	6.06	5.56	5.67	5.42	5.63
Days Sales Outstanding (DSO)	68.06	67.72	68.35	80.85	72.19	67.24	63.46	72.47	72.79	70.02	71.83
Days Inventory Outstanding (DIO)	82.96	79.57	85.75	96.78	82.94	71.36	68.85	75.68	74.57	68.70	70.04
Days Payable Outstanding (DPO)	65.39	72.30	70.32	78.39	67.54	66.41	60.20	65.64	64.34	67.34	64.78
Cash Conversion Cycle (CCC)	85.62	74.99	83.79	99.24	87.60	72.18	72.10	82.51	83.03	71.38	77.10
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,399	4,439	4,633	11,709	11,506	11,441	11,526	11,531	11,605	11,721	12,010
Invested Capital Turnover	1.23	1.26	1.24	0.75	0.85	0.93	0.98	0.72	0.73	0.74	0.73
Increase / (Decrease) in Invested Capital	97	122	111	7,219	7,107	7,002	6,893	-178	99	280	484
Enterprise Value (EV)	16,596	20,341	19,642	21,908	23,249	28,459	32,407	34,073	33,810	29,234	30,228
Market Capitalization	15,412	19,396	18,587	20,098	21,673	27,184	31,076	32,883	32,798	28,099	29,034
Book Value per Share	$17.84	$19.39	$19.85	$54.81	$41.23	$42.17	$42.15	$42.65	$43.61	$43.80	$44.50
Tangible Book Value per Share	($1.97)	($0.86)	($0.42)	($2.20)	($1.07)	$0.21	$0.96	$1.89	$2.77	$1.16	$1.74
Total Capital	5,585	5,383	5,470	12,417	12,211	12,460	12,473	12,346	12,594	12,898	13,069
Total Debt	2,363	1,880	1,881	2,507	2,270	2,284	2,270	1,998	1,994	2,016	2,015
Total Long-Term Debt	1,880	1,880	1,881	2,267	2,253	2,268	1,985	1,981	1,977	1,978	1,974
Net Debt	1,177	936	1,044	1,799	1,565	1,265	1,323	1,183	1,005	895	956
Capital Expenditures (CapEx)	53	59	49	54	72	95	73	71	74	99	66
Debt-free, Cash-free Net Working Capital (DFCFNWC)	559	478	679	985	843	676	900	941	989	679	900
Debt-free Net Working Capital (DFNWC)	1,745	1,422	1,516	1,693	1,548	1,695	1,847	1,756	1,978	1,800	1,959
Net Working Capital (NWC)	1,262	1,422	1,516	1,453	1,531	1,679	1,562	1,739	1,961	1,762	1,918
Net Nonoperating Expense (NNE)	107	6.31	3.93	4.04	4.93	1.27	10	4.71	8.87	-94	11
Net Nonoperating Obligations (NNO)	1,177	936	1,044	1,799	1,565	1,265	1,323	1,183	1,005	839	956
Total Depreciation and Amortization (D&A)	58	60	60	92	147	137	134	145	141	142	145
Debt-free, Cash-free Net Working Capital to Revenue	10.47%	8.66%	11.92%	16.26%	12.49%	9.18%	11.32%	11.21%	11.74%	7.93%	10.47%
Debt-free Net Working Capital to Revenue	32.68%	25.75%	26.61%	27.96%	22.93%	23.02%	23.24%	20.91%	23.48%	21.02%	22.78%
Net Working Capital to Revenue	23.64%	25.75%	26.61%	23.99%	22.67%	22.80%	19.65%	20.71%	23.28%	20.58%	22.31%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.07	$0.83	$0.55	$0.45	$0.63	$1.18	$0.63	$0.80	$0.89	$1.35	$0.69
Adjusted Weighted Average Basic Shares Outstanding	180.22M	180.22M	180.40M	205.54M	240.87M	217.01M	241.85M	242.57M	242.93M	242.58M	243.11M
Adjusted Diluted Earnings per Share	$0.07	$0.82	$0.54	$0.45	$0.63	$1.17	$0.63	$0.80	$0.89	$1.33	$0.69
Adjusted Weighted Average Diluted Shares Outstanding	180.94M	180.98M	181.32M	206.74M	242.19M	218.18M	243.02M	243.54M	243.75M	243.52M	243.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	180.22M	180.28M	180.62M	240.83M	241.08M	241.77M	242.45M	242.89M	242.94M	243.05M	243.35M
Normalized Net Operating Profit after Tax (NOPAT)	129	161	109	119	174	161	171	217	229	254	194
Normalized NOPAT Margin	9.36%	10.68%	7.54%	6.89%	8.39%	7.60%	8.41%	9.99%	10.89%	11.25%	9.37%
Pre Tax Income Margin	1.23%	12.55%	8.70%	6.62%	8.91%	9.92%	9.64%	11.39%	12.79%	16.62%	10.49%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.42	15.54	15.00	10.50	14.21	16.00	15.00	23.45	27.90	25.78	28.13
NOPAT to Interest Expense	9.88	11.95	11.44	8.00	11.21	19.09	11.65	18.06	22.59	25.79	22.22
EBIT Less CapEx to Interest Expense	-2.00	11.00	9.56	6.00	9.07	9.21	9.79	17.00	20.50	14.78	19.88
NOPAT Less CapEx to Interest Expense	5.47	7.41	5.99	3.50	6.07	12.30	6.44	11.61	15.19	14.79	13.97
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	67.08%	61.13%	59.68%	69.89%	55.49%	49.10%	49.32%	43.79%	41.33%	39.33%	39.82%
Augmented Payout Ratio	83.39%	75.77%	62.10%	72.44%	57.52%	53.20%	54.15%	48.24%	45.42%	41.57%	41.81%

Frequently Asked Questions About Xylem's Financials

When does Xylem's fiscal year end?

According to the most recent income statement we have on file, Xylem's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Xylem's net income changed over the last 9 years?

Xylem's net income appears to be on an upward trend, with a most recent value of $890 million in 2024, rising from $340 million in 2015. The previous period was $609 million in 2023. Check out Xylem's forecast to explore projected trends and price targets.

What is Xylem's operating income?

Xylem's total operating income in 2024 was $1.01 billion, based on the following breakdown:

Total Gross Profit: $3.21 billion
Total Operating Expenses: $2.20 billion

How has Xylem revenue changed over the last 9 years?

Over the last 9 years, Xylem's total revenue changed from $3.65 billion in 2015 to $8.56 billion in 2024, a change of 134.4%.

How much debt does Xylem have?

Xylem's total liabilities were at $5.61 billion at the end of 2024, a 5.5% decrease from 2023, and a 118.1% increase since 2015.

How much cash does Xylem have?

In the past 9 years, Xylem's cash and equivalents has ranged from $296 million in 2018 to $1.88 billion in 2020, and is currently $1.12 billion as of their latest financial filing in 2024.

How has Xylem's book value per share changed over the last 9 years?

Over the last 9 years, Xylem's book value per share changed from 11.62 in 2015 to 43.80 in 2024, a change of 277.0%.

Related Companies

This page (NYSE:XYL) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xylem (XYL) Financials

Frequently Asked Questions About Xylem's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Xylem (XYL) Financials

Annual Income Statements for Xylem

Quarterly Income Statements for Xylem

Annual Cash Flow Statements for Xylem

Quarterly Cash Flow Statements for Xylem

Annual Balance Sheets for Xylem

Quarterly Balance Sheets for Xylem

Annual Metrics and Ratios for Xylem

Quarterly Metrics and Ratios for Xylem

Frequently Asked Questions About Xylem's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools